Home / Import refusals / 799-3709683-2/11/1

FDA Import Refusal 799-3709683-2/11/1 — Taisho Pharmaceutical Co., Ltd.

Taisho Pharmaceutical Co., Ltd. — FEI 3002808317

The FDA refused shipment 799-3709683-2/11/1 from Taisho Pharmaceutical Co., Ltd. (Japan) on March 22, 2023. The refused product falls under Drugs and Biologics — IBUPROFEN (ANTI-INFLAMMATORY). Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
March 22, 2023
Country
Japan
Product Category
Drugs and Biologics
Product Code
62GAB41 IBUPROFEN (ANTI-INFLAMMATORY)
Charges
75

Recent inspections

  • 1087840 (VAI Fri Mar 29 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 951450 (VAI Fri Nov 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time))

Other import refusals

  • 799-3383332-9/11/1 (Fri Feb 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-0174291-6/11/1 (Wed Jul 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • SCS-1316175-9/71/1 (Thu Aug 20 2020 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-8229756-4/11/1 (Wed Aug 19 2020 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-7538629-1/11/1 (Mon Aug 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources